Does CYCLOSPORINE Cause Product packaging quantity issue? 206 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 206 reports of Product packaging quantity issue have been filed in association with CYCLOSPORINE (Verkazia). This represents 0.3% of all adverse event reports for CYCLOSPORINE.
206
Reports of Product packaging quantity issue with CYCLOSPORINE
0.3%
of all CYCLOSPORINE reports
0
Deaths
1
Hospitalizations
How Dangerous Is Product packaging quantity issue From CYCLOSPORINE?
Of the 206 reports, 1 (0.5%) required hospitalization.
Is Product packaging quantity issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CYCLOSPORINE. However, 206 reports have been filed with the FAERS database.
What Other Side Effects Does CYCLOSPORINE Cause?
Drug ineffective (11,172)
Off label use (6,860)
Eye irritation (5,806)
Product use in unapproved indication (5,019)
Condition aggravated (2,310)
Eye pain (2,197)
Drug intolerance (2,176)
Pneumonia (2,022)
Pyrexia (2,020)
Treatment failure (1,961)
What Other Drugs Cause Product packaging quantity issue?
LEUPROLIDE (523)
ALBUTEROL (431)
BUDESONIDE\FORMOTEROL (301)
FENTANYL (286)
BUPRENORPHINE (225)
ESTRADIOL (201)
BIMATOPROST (177)
RIVAROXABAN (174)
EXENATIDE (154)
LIFITEGRAST (153)
Which CYCLOSPORINE Alternatives Have Lower Product packaging quantity issue Risk?
CYCLOSPORINE vs CYCLOSPORINE A
CYCLOSPORINE vs CYMBALTA
CYCLOSPORINE vs CYNODON DACTYLON POLLEN
CYCLOSPORINE vs CYPROHEPTADINE
CYCLOSPORINE vs CYPROTERONE